Effects of granulosa cell-specific deletion of Rb in Inha-α null female mice

Endocrinology

Volumn 148, Issue 8, 2007, Pages 3837-3849

  Andreu Vieyra, Claudia ^a   Chen, Ruihong ^a   Matzuk, Martin M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBIN; PROTEASOME; PROTEIN P107; PROTEIN P130; PROTEIN P27; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL SPECIFICITY; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE LOSS; GRANULOSA CELL; MITOSIS; MORTALITY; MOUSE; NONHUMAN; OVARY CELL; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; APOPTOSIS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GRANULOSA CELL TUMOR; GRANULOSA CELLS; HEMORRHAGE; INHIBINS; LUTEINIZING HORMONE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOSIS; PROGESTERONE; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; RETINOBLASTOMA-LIKE PROTEIN P130; SURVIVAL RATE;

EID: 34547111044     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1590     Document Type: Article

References (80)

1. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A 1999 The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20:501-534
2. Elledge SJ, Winston J, Harper JW 1996 A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol 6:388-392
3. Grana X, Garriga J, Mayol X 1998 Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17:3365-3383
4. Classon M, Harlow E 2002 The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2:910-917
5. Nevins JR 2001 The Rb/E2F pathway and cancer. Hum Mol Genet 10:699-703
6. Harbour JW, Dean DC 2000 The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 14:2393-2409
7. Harbour JW, Dean DC 2000 Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2:E65-E67
8. Delston RB, Harbour JW 2006 Rb at the interface between cell cycle and apoptotic decisions. Curr Mol Med 6:713-718
9. Rolaki A, Drakakis P, Millingos S, Loutradis D, Makrigiannakis A 2005 Novel trends in follicular development, atresia and corpus luteum regression: a role for apoptosis. Reprod Biomed Online 11:93-103
10. Robker RL, Richards JS 1998 Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol Endocrinol 12:924-940
11. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA 1996 Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470-474
12. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY 1996 Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720
13. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A 1996 Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721-732
14. Jirawatnotai S, Moons DS, Stocco CO, Franks R, Hales DB, Gibori G, Kiyokawa H 2003 The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 cooperate to restrict proliferative life span in differentiating ovarian cells. J Biol Chem 278:17021-17027
15. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ 1995 Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557
16. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P 1995 Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684
17. Ogawa T, Yogo K, Ishida N, Takeya T 2003 Synergistic effects of activin and FSH on hyperphosphorylation of Rb and G1/S transition in rat primary granulosa cells. Mol Cell Endocrinol 210:31-38
18. Bachman KE, Park BH 2005 Duel nature of TGF-β signaling: tumor suppressor vs. tumor promoter. Curr Opin Oncol 17:49-54
19. Matzuk MM, Kumar TR, Shou W, Coerver KA, Lau AL, Behringer RR, Finegold MJ 1996 Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog Horm Res 51: 123-154; discussion 155-157
20. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A 1992 α-Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313-319
21. Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H, Bradley A 1994 Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA 91:8817-8821
22. Burns KH, Owens GE, Ogbonna SC, Nilson JH, Matzuk MM 2003 Expression profiling analyses of gonadotropin responses and tumor development in the absence of inhibins. Endocrinology 144:4492-4507
23. Kumar TR, Palapattu G, Wang P, Woodruff TK, Boime I, Byrne MC, Matzuk MM 1999 Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis. Mol Endocrinol 13:851-865
24. Kumar TR, Wang Y, Matzuk MM 1996 Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice. Endocrinology 137:4210-4216
25. Coerver KA, Woodruff TK, Finegold MJ, Mather J, Bradley A, Matzuk MM 1996 Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Mol Endocrinol 10:534-543
26. Burns KH, Agno JE, Sicinski P, Matzuk MM 2003 Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin α knockout mice. Mol Endocrinol 17:2053-2069
27. Cipriano SC, Chen L, Burns KH, Koff A, Matzuk MM 2001 Inhibin and p27 interact to regulate gonadal tumorigenesis. Mol Endocrinol 15:985-996
28. Scambia G, Lovergine S, Masciullo V 2006 RB family members as predictive and prognostic factors in human cancer. Oncogene 25:5302-5308
29. Lazzerini Denchi E, Helin K 2005 E2F1 is crucial for E2F-dependent apoptosis. EMBO Rep 6:661-668
30. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA 1992 Effects of an Rb mutation in the mouse. Nature 359:295-300
31. Wikenheiser-Brokamp KA 2006 Retinoblastoma family proteins: insights gained through genetic manipulation of mice. Cell Mol Life Sci 63:767-780
32. MacPherson D, Sage J, Crowley D, Trumpp A, Bronson RT, Jacks T 2003 Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system. Mol Cell Biol 23:1044-1053
33. Marino S, Vooijs M, van Der Gulden H, Jonkers J, Berns A 2000 Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev 14:994-1004
34. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A 2003 Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4:181-189
35. Minna JD, Kurie JM, Jacks T 2003 A big step in the study of small cell lung cancer. Cancer Cell 4:163-166
36. Flesken-Nikitin A, Choi KC, Eng JP, Shmidt EN, Nikitin AY 2003 Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res 63:3459-3463
37. Vooijs M, van der Valk M, te Riele H, Berns A 1998 Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse. Oncogene 17:1-12
38. Pangas SA, Li X, Robertson EJ, Matzuk MM 2006 Premature luteinization and cumulus cell defects in ovarian-specific Smad4 knockout mice. Mol Endocrinol 20:1406-1422
39. Cipriano SC, Chen L, Kumar TR, Matzuk MM 2000 Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice. Endocrinology 141:2319-2327
40. Grimm SL, Contreras A, Barcellos-Hoff MH, Rosen JM 2005 Cell cycle defects contribute to a block in hormone-induced mammary gland proliferation in CCAAT/enhancer-binding protein (C/EBPβ)-null mice. J Biol Chem 280:36301-36309
41. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H 1984 Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715
42. Samuel MA, Morrey JD, Diamond MS 2007 Caspase-3 dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. J Virol 81:2614-2623
43. Elvin JA, Yan C, Matzuk MM 2000 Growth differentiation factor-9 stimulates progesterone synthesis in granulosa cells via a prostaglandin E2/EP2 receptor pathway. Proc Natl Acad Sci USA 97:10288-10293
44. Pangas SA, Jorgez CJ, Matzuk MM 2004 Growth differentiation factor 9 regulates expression of the bone morphogenetic protein antagonist gremlin. J Biol Chem 279:32281-32286
45. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR 2003 Genetic studies of the AMH/MIS signaling pathway for Mullerian duct regression. Mol Cell Endocrinol 211:15-19
46. Jorgez CJ, Klysik M, Jamin SP, Behringer RR, Matzuk MM 2004 Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol Endocrinol 18:953-967
47. Jeyasuria P, Ikeda Y, Jamin SP, Zhao L, De Rooij DG, Themmen AP, Behringer RR, Parker KL 2004 Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol Endocrinol 18:1610-1619
48. Boerboom D, Paquet M, Hsieh M, Liu J, Jamin SP, Behringer RR, Sirois J, Taketo MM, Richards JS 2005 Misregulated Wnt/β-catenin signaling leads to ovarian granulosa cell tumor development. Cancer Res 65:9206-9215
49. Buchmann AM, Swaminathan S, Thimmapaya B 1998 Regulation of cellular genes in a chromosomal context by the retinoblastoma tumor suppressor protein. Mol Cell Biol 18:4565-4576
50. Hiyama H, Iavarone A, LaBaer J, Reeves SA 1997 Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene 14:2533-2542
51. Andreu-Vieyra CV, Habibi HR 2000 Factors controlling ovarian apoptosis. Can J Physiol Pharmacol 78:1003-1012
52. Earnshaw WC, Martins LM, Kaufmann SH 1999 Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383-424
53. Ji P, Jiang H, Rekhtman K, Bloom J, Ichetovkin M, Pagano M, Zhu L 2004 An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol Cell 16:47-58
54. Slingerland J, Pagano M 2000 Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183:10-17
55. Lu Y, Zi X, Pollak M 2004 Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells. Int J Cancer 108:334-341
56. Dupont J, Le Roith D 2001 Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects. Mol Pathol 54:149-154
57. Mulligan GJ, Wong J, Jacks T 1998 p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB. Mol Cell Biol 18:206-220
58. Donovan SL, Schweers B, Martins R, Johnson D, Dyer MA 2006 Compensation by tumor suppressor genes during retinal development in mice and humans. BMC Biol 4:14
59. Soprano KJ, Purev E, Vuocolo S, Soprano DR 2006 Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid. Oncogene 25:5315-5325
60. Messinis IE 2006 Ovarian feedback, mechanism of action and possible clinical implications. Hum Reprod Update 12:557-571
61. Turgeon JL, Waring DW 2006 Differential expression and regulation of progesterone receptor isoforms in rat and mouse pituitary cells and LβT2 gonadotropes. J Endocrinol 190:837-846
62. Van Niekerk CC, Ramaekers FC, Hanselaar AG, Aldeweireldt J, Poels LG 1993 Changes in expression of differentiation markers between normal ovarian cells and derived tumors. Am J Pathol 142:157-177
63. Pan J, Kwan RW, Auersperg N 1995 Keratin expression and steroidogenesis in rat granulosa cells, transformed with the Kirsten-ras and SV40 oncogenes singly and in combination. Mol Cell Endocrinol 112:231-239
64. Anderson E, Lee GY 1997 The polycystic ovarian (PCO) condition: apoptosis and epithelialization of the ovarian antral follicles are aspects of cystogenesis in the dehydroepiandrosterone (DHEA)-treated rat model. Tissue Cell 29:171-189
65. Abbott DH, Dumesic DA, Franks S 2002 Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 174:1-5
66. Bracken AP, Ciro M, Cocito A, Helin K 2004 E2F target genes: unraveling the biology. Trends Biochem Sci 29:409-417
67. Halazonetis TD, Bartek J 2006 DNA damage signaling recruits the RNA polymerase II binding protein Che-1 to the p53 promoter. Mol Cell 24:809-810
68. van Deursen JM 2007 Rb loss causes cancer by driving mitosis mad. Cancer Cell 11:1-3
69. Pickering MT, Kowalik TF 2006 Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation. Oncogene 25:746-755
70. Wu X, Levine AJ 1994 p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 91:3602-3606
71. Roos WP, Kaina B 2006 DNA damage-induced cell death by apoptosis. Trends Mol Med 12:440-450
72. Ji P, Zhu L 2005 Using kinetic studies to uncover new Rb functions in inhibiting cell cycle progression. Cell Cycle 4:373-375
73. Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, Kitagawa K, Shirane M, Tsunematsu R, Tsukiyama T, Ishida N, Kitagawa M, Hatakeyama S 2000 Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J 19:2069-2081
74. Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, Hatakeyama S, Kitagawa M, Iemura S, Natsume T, Nakayama KI 2004 Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 6:661-672
75. Alexiadis M, Mamers P, Chu S, Fuller PJ 2006 Insulin-like growth factor, insulin-like growth factor-binding protein-4, and pregnancy-associated plasma protein-A gene expression in human granulosa cell tumors. Int J Gynecol Cancer 16:1973-1979
76. Kolodziejczyk J, Gertler A, Leibovich H, Rzasa J, Gregoraszczuk EL 2003 Synergistic action of growth hormone and insulin-like growth factor I (IGF-I) on proliferation and estradiol secretion in porcine granulosa and theca cells cultured alone or in coculture. Theriogenology 60:559-570
77. Richards JS, Russell DL, Ochsner S, Hsieh M, Doyle KH, Falender AE, Lo YK, Sharma SC 2002 Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog Horm Res 57:195-220
78. Mulligan G, Jacks T 1998 The retinoblastoma gene family: cousins with overlapping interests. Trends Genet 14:223-229
79. Classon M, Dyson N 2001 p107 and p130: versatile proteins with interesting pockets. Exp Cell Res 264:135-147
80. Rodier G, Makris C, Coulombe P, Scime A, Nakayama K, Nakayama KI, Meloche S 2005 p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2. J Cell Biol 168:55-66